((Automated translation by Reuters, please see disclaimer https://bit.ly/rtrsauto))
US Food and Drug Administration approves Merck’s next-generation vaccine
MRK.N to protect adults against pneumococcal disease, according to a letter posted Monday on the health regulator’s website.